MARK TWAIN MEDICAL CENTER
1. Target Overview & Investment Thesis
MARK TWAIN MEDICAL CENTER is a 25-bed rural/critical access in CALAVERAS, CA with $69.3M in net patient revenue and a -15.8% operating margin. The hospital serves a payer mix of 56.9% Medicare, 4.1% Medicaid, and 39.0% commercial.
Thesis: Turnaround. Our ML models identify $5.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.8% to -8.4% (+736bps).
| Net Revenue HCRIS | $69.3M |
| Current EBITDA COMPUTED | $-11.0M |
| Operating Margin COMPUTED | -15.8% |
| Occupancy HCRIS | 31.5% |
| Revenue / Bed COMPUTED | $2.8M |
| Net-to-Gross HCRIS | 35.0% |
| Distress Probability ML | 51.7% |
2. Market Context & Competitive Position
CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -15.8% places it below the state median. Among 71 size-comparable peers (12-50 beds), the median margin is -7.2%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (12-50), prioritizing same-state peers. 71 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| MARK TWAIN MEDICAL CENTER (Target) | CA | 25 | $69.3M | -15.8% |
| TAHOE FOREST HOSPITAL | CA | 25 | $264.3M | 13.0% |
| PORTERVILLE DEVELOPMENTAL CENT | CA | 17 | $193.6M | -6.0% |
| ADVENTIST HEALTH REEDLEY | CA | 49 | $187.1M | 1.8% |
| SUTTER DAVIS HOSPITAL | CA | 48 | $176.9M | 12.5% |
| ADVENTIST HEALTH UKIAH VALLEY | CA | 50 | $173.4M | -39.9% |
| ADVENTIST HEALTH CLEARLAKE | CA | 25 | $159.9M | -6.3% |
| ST ELIZABETH COMMUNITY HOSPTI | CA | 49 | $159.2M | 3.5% |
| RIDGECREST REGIONAL HOSPITAL | CA | 25 | $149.6M | -14.7% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $5.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.5M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.4M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.4M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $843K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $44K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-11.0M |
| + RCM Uplift | +$5.1M |
| Pro Forma EBITDA | $-5.9M |
| Current Margin | -15.8% |
| Pro Forma Margin | -8.4% |
| WC Released (1x) | $2.7M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-16.9M | $-21.2M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-16.9M | $-28.8M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-15.2M | $-17.5M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-15.2M | $-23.5M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-18.5M | $-41.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-18.5M | $-51.4M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Heavy Medicare dependence | Medicare comprises 56.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement |
| Medium | Low occupancy | At 31.5%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 51.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 71 hospitals with 12-50 beds
- Same-state prioritization (n=72)
- Comp margins: P25=-18.6% / P50=-7.2% / P75=1.8%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.